Dissemin is shutting down on January 1st, 2025

Published in

Springer, Cancer Immunology, Immunotherapy, 5(71), p. 1093-1101, 2021

DOI: 10.1007/s00262-021-03052-w

Links

Tools

Export citation

Search in Google Scholar

Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO